+ Follow PROVIGIL Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 239338
[Title] => New drugs for 2004
[Summary] => Some of the most outstanding stories in medicine in 2004 will involve new drugs to treat an assortment of ills, new uses for existing medications, and the possible availability of some drugs now sold only by prescription to over-the-counter status.
Here are the drugs that are expected to produce a significant impact on health care in 2004.
Cancer. A highly anticipated class of cancer drugs called anti-angiogenesis agents may finally become available. Anti-angiogenesis agents act by blocking the formation and growth of new blood vessels that feed tumors.
[DatePublished] => 2004-02-17 00:00:00
[ColumnID] => 133436
[Focus] => 0
[AuthorID] => 1778504
[AuthorName] => Tyrone M. Reyes M.D.
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
)
)
PROVIGIL
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 239338
[Title] => New drugs for 2004
[Summary] => Some of the most outstanding stories in medicine in 2004 will involve new drugs to treat an assortment of ills, new uses for existing medications, and the possible availability of some drugs now sold only by prescription to over-the-counter status.
Here are the drugs that are expected to produce a significant impact on health care in 2004.
Cancer. A highly anticipated class of cancer drugs called anti-angiogenesis agents may finally become available. Anti-angiogenesis agents act by blocking the formation and growth of new blood vessels that feed tumors.
[DatePublished] => 2004-02-17 00:00:00
[ColumnID] => 133436
[Focus] => 0
[AuthorID] => 1778504
[AuthorName] => Tyrone M. Reyes M.D.
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
)
)
abtest